APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Prostate Cancer Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Prostate Cancer Vaccines Market Analysis and Forecast 2026-2032

Report ID 174029380219 December 2025207 pages

Choose your research edition.

Industry ResearchProstate Cancer Vaccines Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostate Cancer Vaccines Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Prostate Cancer Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostate Cancer Vaccines Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostate Cancer Vaccines Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Prostate Cancer Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Prostate Cancer Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Prostate Cancer Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Prostate Cancer Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Prostate Cancer Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Prostate Cancer Vaccines include Pfizer Inc., Vaccitech, Vaccibody AS, Ultimovacs, UbiVac, SOTIO, Sensei Biotherapeutics, Oncovir Inc. and OncBioMune Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Prostate Cancer Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Prostate Cancer Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Prostate Cancer Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prostate Cancer Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Prostate Cancer Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Prostate Cancer Vaccines sales, projected growth trends, production technology, application and end-user industry.

Prostate Cancer Vaccines Segment by Company

Pfizer Inc.

Vaccitech

Vaccibody AS

Ultimovacs

UbiVac

SOTIO

Sensei Biotherapeutics

Oncovir Inc.

OncBioMune Pharmaceuticals

Momotaro-Gene Inc.

Mediolanum Farmaceutici

Medigene AG

Dendreon Corporation

Curevac AG

Cleveland BioLabs Inc.

Bavarian Nordic

AlphaVax Inc.

Advaxis immunotherapies

Advantagene

Prostate Cancer Vaccines Segment by Type

Tablet

Injection

Prostate Cancer Vaccines Segment by Application

Hospital

Clinic

Others

Prostate Cancer Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostate Cancer Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostate Cancer Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostate Cancer Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Prostate Cancer Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Prostate Cancer Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostate Cancer Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prostate Cancer Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablet Major Manufacturers Table 3. Injection Major Manufacturers Table 4. Global Prostate Cancer Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Others Major Manufacturers Table 8. Prostate Cancer Vaccines Industry Trends Table 9. Prostate Cancer Vaccines Industry Drivers Table 10. Prostate Cancer Vaccines Industry Opportunities and Challenges Table 11. Prostate Cancer Vaccines Industry Restraints Table 12. Global Prostate Cancer Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Prostate Cancer Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Prostate Cancer Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Prostate Cancer Vaccines Revenue Market Share by Region (2021-2026) Table 16. Global Prostate Cancer Vaccines Revenue Market Share by Region (2027-2032) Table 17. Global Prostate Cancer Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Prostate Cancer Vaccines Sales by Region (2021-2026) & (K Units) Table 19. Global Prostate Cancer Vaccines Sales by Region (2027-2032) & (K Units) Table 20. Global Prostate Cancer Vaccines Sales Market Share by Region (2021-2026) Table 21. Global Prostate Cancer Vaccines Sales Market Share by Region (2027-2032) Table 22. Global Prostate Cancer Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Prostate Cancer Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Prostate Cancer Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Prostate Cancer Vaccines Sales Market Share by Manufacturers (2021-2026) Table 26. Global Prostate Cancer Vaccines Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Prostate Cancer Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Prostate Cancer Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Prostate Cancer Vaccines Manufacturers, Product Type & Application Table 30. Global Prostate Cancer Vaccines Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Prostate Cancer Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Prostate Cancer Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Prostate Cancer Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Prostate Cancer Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Prostate Cancer Vaccines Revenue Market Share by Type (2021-2026) Table 37. Global Prostate Cancer Vaccines Revenue Market Share by Type (2027-2032) Table 38. Global Prostate Cancer Vaccines Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Prostate Cancer Vaccines Sales by Type (2021-2026) & (K Units) Table 40. Global Prostate Cancer Vaccines Sales by Type (2027-2032) & (K Units) Table 41. Global Prostate Cancer Vaccines Sales Market Share by Type (2021-2026) Table 42. Global Prostate Cancer Vaccines Sales Market Share by Type (2027-2032) Table 43. Global Prostate Cancer Vaccines Price by Type (2021-2026) & (US$/Unit) Table 44. Global Prostate Cancer Vaccines Price by Type (2027-2032) & (US$/Unit) Table 45. Global Prostate Cancer Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Prostate Cancer Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Prostate Cancer Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Prostate Cancer Vaccines Revenue Market Share by Application (2021-2026) Table 49. Global Prostate Cancer Vaccines Revenue Market Share by Application (2027-2032) Table 50. Global Prostate Cancer Vaccines Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Prostate Cancer Vaccines Sales by Application (2021-2026) & (K Units) Table 52. Global Prostate Cancer Vaccines Sales by Application (2027-2032) & (K Units) Table 53. Global Prostate Cancer Vaccines Sales Market Share by Application (2021-2026) Table 54. Global Prostate Cancer Vaccines Sales Market Share by Application (2027-2032) Table 55. Global Prostate Cancer Vaccines Price by Application (2021-2026) & (US$/Unit) Table 56. Global Prostate Cancer Vaccines Price by Application (2027-2032) & (US$/Unit) Table 57. Pfizer Inc. Company Information Table 58. Pfizer Inc. Business Overview Table 59. Pfizer Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Pfizer Inc. Prostate Cancer Vaccines Product Portfolio Table 61. Pfizer Inc. Recent Development Table 62. Vaccitech Company Information Table 63. Vaccitech Business Overview Table 64. Vaccitech Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Vaccitech Prostate Cancer Vaccines Product Portfolio Table 66. Vaccitech Recent Development Table 67. Vaccibody AS Company Information Table 68. Vaccibody AS Business Overview Table 69. Vaccibody AS Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Vaccibody AS Prostate Cancer Vaccines Product Portfolio Table 71. Vaccibody AS Recent Development Table 72. Ultimovacs Company Information Table 73. Ultimovacs Business Overview Table 74. Ultimovacs Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Ultimovacs Prostate Cancer Vaccines Product Portfolio Table 76. Ultimovacs Recent Development Table 77. UbiVac Company Information Table 78. UbiVac Business Overview Table 79. UbiVac Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. UbiVac Prostate Cancer Vaccines Product Portfolio Table 81. UbiVac Recent Development Table 82. SOTIO Company Information Table 83. SOTIO Business Overview Table 84. SOTIO Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. SOTIO Prostate Cancer Vaccines Product Portfolio Table 86. SOTIO Recent Development Table 87. Sensei Biotherapeutics Company Information Table 88. Sensei Biotherapeutics Business Overview Table 89. Sensei Biotherapeutics Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Sensei Biotherapeutics Prostate Cancer Vaccines Product Portfolio Table 91. Sensei Biotherapeutics Recent Development Table 92. Oncovir Inc. Company Information Table 93. Oncovir Inc. Business Overview Table 94. Oncovir Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Oncovir Inc. Prostate Cancer Vaccines Product Portfolio Table 96. Oncovir Inc. Recent Development Table 97. OncBioMune Pharmaceuticals Company Information Table 98. OncBioMune Pharmaceuticals Business Overview Table 99. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Product Portfolio Table 101. OncBioMune Pharmaceuticals Recent Development Table 102. Momotaro-Gene Inc. Company Information Table 103. Momotaro-Gene Inc. Business Overview Table 104. Momotaro-Gene Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Momotaro-Gene Inc. Prostate Cancer Vaccines Product Portfolio Table 106. Momotaro-Gene Inc. Recent Development Table 107. Mediolanum Farmaceutici Company Information Table 108. Mediolanum Farmaceutici Business Overview Table 109. Mediolanum Farmaceutici Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Mediolanum Farmaceutici Prostate Cancer Vaccines Product Portfolio Table 111. Mediolanum Farmaceutici Recent Development Table 112. Medigene AG Company Information Table 113. Medigene AG Business Overview Table 114. Medigene AG Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Medigene AG Prostate Cancer Vaccines Product Portfolio Table 116. Medigene AG Recent Development Table 117. Dendreon Corporation Company Information Table 118. Dendreon Corporation Business Overview Table 119. Dendreon Corporation Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Dendreon Corporation Prostate Cancer Vaccines Product Portfolio Table 121. Dendreon Corporation Recent Development Table 122. Curevac AG Company Information Table 123. Curevac AG Business Overview Table 124. Curevac AG Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Curevac AG Prostate Cancer Vaccines Product Portfolio Table 126. Curevac AG Recent Development Table 127. Cleveland BioLabs Inc. Company Information Table 128. Cleveland BioLabs Inc. Business Overview Table 129. Cleveland BioLabs Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Cleveland BioLabs Inc. Prostate Cancer Vaccines Product Portfolio Table 131. Cleveland BioLabs Inc. Recent Development Table 132. Bavarian Nordic Company Information Table 133. Bavarian Nordic Business Overview Table 134. Bavarian Nordic Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Bavarian Nordic Prostate Cancer Vaccines Product Portfolio Table 136. Bavarian Nordic Recent Development Table 137. AlphaVax Inc. Company Information Table 138. AlphaVax Inc. Business Overview Table 139. AlphaVax Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. AlphaVax Inc. Prostate Cancer Vaccines Product Portfolio Table 141. AlphaVax Inc. Recent Development Table 142. Advaxis immunotherapies Company Information Table 143. Advaxis immunotherapies Business Overview Table 144. Advaxis immunotherapies Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Advaxis immunotherapies Prostate Cancer Vaccines Product Portfolio Table 146. Advaxis immunotherapies Recent Development Table 147. Advantagene Company Information Table 148. Advantagene Business Overview Table 149. Advantagene Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Advantagene Prostate Cancer Vaccines Product Portfolio Table 151. Advantagene Recent Development Table 152. North America Prostate Cancer Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 153. North America Prostate Cancer Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 154. North America Prostate Cancer Vaccines Sales by Type (2021-2026) & (K Units) Table 155. North America Prostate Cancer Vaccines Sales by Type (2027-2032) & (K Units) Table 156. North America Prostate Cancer Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 157. North America Prostate Cancer Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 158. North America Prostate Cancer Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 159. North America Prostate Cancer Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 160. North America Prostate Cancer Vaccines Sales by Application (2021-2026) & (K Units) Table 161. North America Prostate Cancer Vaccines Sales by Application (2027-2032) & (K Units) Table 162. North America Prostate Cancer Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 163. North America Prostate Cancer Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 164. North America Prostate Cancer Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. North America Prostate Cancer Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. North America Prostate Cancer Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. North America Prostate Cancer Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 168. North America Prostate Cancer Vaccines Sales by Country (2021-2026) & (K Units) Table 169. North America Prostate Cancer Vaccines Sales by Country (2027-2032) & (K Units) Table 170. North America Prostate Cancer Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 171. North America Prostate Cancer Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 172. United States Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 173. Canada Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 174. Europe Prostate Cancer Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 175. Europe Prostate Cancer Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 176. Europe Prostate Cancer Vaccines Sales by Type (2021-2026) & (K Units) Table 177. Europe Prostate Cancer Vaccines Sales by Type (2027-2032) & (K Units) Table 178. Europe Prostate Cancer Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 179. Europe Prostate Cancer Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 180. Europe Prostate Cancer Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 181. Europe Prostate Cancer Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 182. Europe Prostate Cancer Vaccines Sales by Application (2021-2026) & (K Units) Table 183. Europe Prostate Cancer Vaccines Sales by Application (2027-2032) & (K Units) Table 184. Europe Prostate Cancer Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 185. Europe Prostate Cancer Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 186. Europe Prostate Cancer Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. Europe Prostate Cancer Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. Europe Prostate Cancer Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. Europe Prostate Cancer Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 190. Europe Prostate Cancer Vaccines Sales by Country (2021-2026) & (K Units) Table 191. Europe Prostate Cancer Vaccines Sales by Country (2027-2032) & (K Units) Table 192. Europe Prostate Cancer Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 193. Europe Prostate Cancer Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 194. Germany Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 195. France Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 196. U.K. Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 197. Italy Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 198. Netherlands Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 199. China Prostate Cancer Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 200. China Prostate Cancer Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 201. China Prostate Cancer Vaccines Sales by Type (2021-2026) & (K Units) Table 202. China Prostate Cancer Vaccines Sales by Type (2027-2032) & (K Units) Table 203. China Prostate Cancer Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 204. China Prostate Cancer Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 205. China Prostate Cancer Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 206. China Prostate Cancer Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 207. China Prostate Cancer Vaccines Sales by Application (2021-2026) & (K Units) Table 208. China Prostate Cancer Vaccines Sales by Application (2027-2032) & (K Units) Table 209. China Prostate Cancer Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 210. China Prostate Cancer Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 211. Asia Prostate Cancer Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 212. Asia Prostate Cancer Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 213. Asia Prostate Cancer Vaccines Sales by Type (2021-2026) & (K Units) Table 214. Asia Prostate Cancer Vaccines Sales by Type (2027-2032) & (K Units) Table 215. Asia Prostate Cancer Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 216. Asia Prostate Cancer Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 217. Asia Prostate Cancer Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 218. Asia Prostate Cancer Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 219. Asia Prostate Cancer Vaccines Sales by Application (2021-2026) & (K Units) Table 220. Asia Prostate Cancer Vaccines Sales by Application (2027-2032) & (K Units) Table 221. Asia Prostate Cancer Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 222. Asia Prostate Cancer Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 223. Asia Prostate Cancer Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 224. Asia Prostate Cancer Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 225. Asia Prostate Cancer Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 226. Asia Prostate Cancer Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 227. Asia Prostate Cancer Vaccines Sales by Country (2021-2026) & (K Units) Table 228. Asia Prostate Cancer Vaccines Sales by Country (2027-2032) & (K Units) Table 229. Asia Prostate Cancer Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 230. Asia Prostate Cancer Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 231. Japan Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 232. South Korea Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 233. India Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 234. Australia Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 235. China Taiwan Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 236. Southeast Asia Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 237. SAMEA Prostate Cancer Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 238. SAMEA Prostate Cancer Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 239. SAMEA Prostate Cancer Vaccines Sales by Type (2021-2026) & (K Units) Table 240. SAMEA Prostate Cancer Vaccines Sales by Type (2027-2032) & (K Units) Table 241. SAMEA Prostate Cancer Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 242. SAMEA Prostate Cancer Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 243. SAMEA Prostate Cancer Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 244. SAMEA Prostate Cancer Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 245. SAMEA Prostate Cancer Vaccines Sales by Application (2021-2026) & (K Units) Table 246. SAMEA Prostate Cancer Vaccines Sales by Application (2027-2032) & (K Units) Table 247. SAMEA Prostate Cancer Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 248. SAMEA Prostate Cancer Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 249. SAMEA Prostate Cancer Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 250. SAMEA Prostate Cancer Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 251. SAMEA Prostate Cancer Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 252. SAMEA Prostate Cancer Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 253. SAMEA Prostate Cancer Vaccines Sales by Country (2021-2026) & (K Units) Table 254. SAMEA Prostate Cancer Vaccines Sales by Country (2027-2032) & (K Units) Table 255. SAMEA Prostate Cancer Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 256. SAMEA Prostate Cancer Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 257. Brazil Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 258. Argentina Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 259. Chile Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 260. Colombia Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 261. Peru Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 262. Saudi Arabia Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 263. Israel Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 264. UAE Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 265. Turkey Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 266. Iran Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 267. Egypt Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Table 268. Key Raw Materials Table 269. Raw Materials Key Suppliers Table 270. Prostate Cancer Vaccines Distributors List Table 271. Prostate Cancer Vaccines Customers List Table 272. Research Programs/Design for This Report Table 273. Authors List of This Report Table 274. Secondary Sources Table 275. Primary Sources List of Figures Figure 1. Prostate Cancer Vaccines Image Figure 2. Global Prostate Cancer Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostate Cancer Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablet Image Figure 5. Injection Image Figure 6. Global Prostate Cancer Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Prostate Cancer Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Prostate Cancer Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Prostate Cancer Vaccines Revenue (2021-2032) & (US$ Million) Figure 13. Global Prostate Cancer Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Prostate Cancer Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Prostate Cancer Vaccines Revenue Market Share by Region (2021-2032) Figure 16. Global Prostate Cancer Vaccines Sales (2021-2032) & (K Units) Figure 17. Global Prostate Cancer Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Prostate Cancer Vaccines Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Prostate Cancer Vaccines Sales YoY (2021-2032) & (K Units) Figure 20. Europe Prostate Cancer Vaccines Sales YoY (2021-2032) & (K Units) Figure 21. China Prostate Cancer Vaccines Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Prostate Cancer Vaccines Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Prostate Cancer Vaccines Sales YoY (2021-2032) & (K Units) Figure 24. Global Prostate Cancer Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Prostate Cancer Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Prostate Cancer Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Prostate Cancer Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Prostate Cancer Vaccines Revenue Market Share by Type (2021-2032) Figure 30. Global Prostate Cancer Vaccines Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Prostate Cancer Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Prostate Cancer Vaccines Sales Market Share by Type (2021-2032) Figure 33. Global Prostate Cancer Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Prostate Cancer Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Prostate Cancer Vaccines Revenue Market Share by Application (2021-2032) Figure 36. Global Prostate Cancer Vaccines Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Prostate Cancer Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Prostate Cancer Vaccines Sales Market Share by Application (2021-2032) Figure 39. North America Prostate Cancer Vaccines Revenue Share by Type (2021-2032) Figure 40. North America Prostate Cancer Vaccines Sales Share by Type (2021-2032) Figure 41. North America Prostate Cancer Vaccines Revenue Share by Application (2021-2032) Figure 42. North America Prostate Cancer Vaccines Sales Share by Application (2021-2032) Figure 43. North America Prostate Cancer Vaccines Revenue Share by Country (2021-2032) Figure 44. North America Prostate Cancer Vaccines Sales Share by Country (2021-2032) Figure 45. Europe Prostate Cancer Vaccines Revenue Share by Type (2021-2032) Figure 46. Europe Prostate Cancer Vaccines Sales Share by Type (2021-2032) Figure 47. Europe Prostate Cancer Vaccines Revenue Share by Application (2021-2032) Figure 48. Europe Prostate Cancer Vaccines Sales Share by Application (2021-2032) Figure 49. Europe Prostate Cancer Vaccines Revenue Share by Country (2021-2032) Figure 50. Europe Prostate Cancer Vaccines Sales Share by Country (2021-2032) Figure 51. China Prostate Cancer Vaccines Revenue Share by Type (2021-2032) Figure 52. China Prostate Cancer Vaccines Sales Share by Type (2021-2032) Figure 53. China Prostate Cancer Vaccines Revenue Share by Application (2021-2032) Figure 54. China Prostate Cancer Vaccines Sales Share by Application (2021-2032) Figure 55. Asia Prostate Cancer Vaccines Revenue Share by Type (2021-2032) Figure 56. Asia Prostate Cancer Vaccines Sales Share by Type (2021-2032) Figure 57. Asia Prostate Cancer Vaccines Revenue Share by Application (2021-2032) Figure 58. Asia Prostate Cancer Vaccines Sales Share by Application (2021-2032) Figure 59. Asia Prostate Cancer Vaccines Revenue Share by Country (2021-2032) Figure 60. Asia Prostate Cancer Vaccines Sales Share by Country (2021-2032) Figure 61. SAMEA Prostate Cancer Vaccines Revenue Share by Type (2021-2032) Figure 62. SAMEA Prostate Cancer Vaccines Sales Share by Type (2021-2032) Figure 63. SAMEA Prostate Cancer Vaccines Revenue Share by Application (2021-2032) Figure 64. SAMEA Prostate Cancer Vaccines Sales Share by Application (2021-2032) Figure 65. SAMEA Prostate Cancer Vaccines Revenue Share by Country (2021-2032) Figure 66. SAMEA Prostate Cancer Vaccines Sales Share by Country (2021-2032) Figure 67. Prostate Cancer Vaccines Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Prostate Cancer Vaccines Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Injection
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Pfizer Inc.
  • Vaccitech
  • Vaccibody AS
  • Ultimovacs
  • UbiVac
  • SOTIO
  • Sensei Biotherapeutics
  • Oncovir Inc.
  • OncBioMune Pharmaceuticals
  • Momotaro-Gene Inc.
  • Mediolanum Farmaceutici
  • Medigene AG
  • Dendreon Corporation
  • Curevac AG
  • Cleveland BioLabs Inc.
  • Bavarian Nordic
  • AlphaVax Inc.
  • Advaxis immunotherapies
  • Advantagene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Prostate Cancer Vaccines Market by Type
  3. 1.2.1 Global Prostate Cancer Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablet
  5. 1.2.3 Injection
  6. 1.3 Prostate Cancer Vaccines Market by Application
  7. 1.3.1 Global Prostate Cancer Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Prostate Cancer Vaccines Market Dynamics
  1. 2.1 Prostate Cancer Vaccines Industry Trends
  2. 2.2 Prostate Cancer Vaccines Industry Drivers
  3. 2.3 Prostate Cancer Vaccines Industry Opportunities and Challenges
  4. 2.4 Prostate Cancer Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Prostate Cancer Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Prostate Cancer Vaccines Revenue by Region
  3. 3.2.1 Global Prostate Cancer Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Prostate Cancer Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Prostate Cancer Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Prostate Cancer Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Prostate Cancer Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Prostate Cancer Vaccines Sales by Region
  9. 3.4.1 Global Prostate Cancer Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Prostate Cancer Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Prostate Cancer Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Prostate Cancer Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Prostate Cancer Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Prostate Cancer Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Prostate Cancer Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Prostate Cancer Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Prostate Cancer Vaccines Sales by Manufacturers
  6. 4.2.1 Global Prostate Cancer Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Prostate Cancer Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Prostate Cancer Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Prostate Cancer Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Prostate Cancer Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Prostate Cancer Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Prostate Cancer Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Prostate Cancer Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Prostate Cancer Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Prostate Cancer Vaccines Tier 1, Tier 2, and Tier 3
5 Prostate Cancer Vaccines Market by Type
  1. 5.1 Global Prostate Cancer Vaccines Revenue by Type
  2. 5.1.1 Global Prostate Cancer Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Prostate Cancer Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Prostate Cancer Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Prostate Cancer Vaccines Sales by Type
  6. 5.2.1 Global Prostate Cancer Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prostate Cancer Vaccines Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Prostate Cancer Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Prostate Cancer Vaccines Price by Type
6 Prostate Cancer Vaccines Market by Application
  1. 6.1 Global Prostate Cancer Vaccines Revenue by Application
  2. 6.1.1 Global Prostate Cancer Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Prostate Cancer Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Prostate Cancer Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Prostate Cancer Vaccines Sales by Application
  6. 6.2.1 Global Prostate Cancer Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Prostate Cancer Vaccines Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Prostate Cancer Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Prostate Cancer Vaccines Price by Application
7 Company Profiles
  1. 7.1 Pfizer Inc.
  2. 7.1.1 Pfizer Inc. Company Information
  3. 7.1.2 Pfizer Inc. Business Overview
  4. 7.1.3 Pfizer Inc. Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Pfizer Inc. Prostate Cancer Vaccines Product Portfolio
  6. 7.1.5 Pfizer Inc. Recent Developments
  7. 7.2 Vaccitech
  8. 7.2.1 Vaccitech Company Information
  9. 7.2.2 Vaccitech Business Overview
  10. 7.2.3 Vaccitech Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Vaccitech Prostate Cancer Vaccines Product Portfolio
  12. 7.2.5 Vaccitech Recent Developments
  13. 7.3 Vaccibody AS
  14. 7.3.1 Vaccibody AS Company Information
  15. 7.3.2 Vaccibody AS Business Overview
  16. 7.3.3 Vaccibody AS Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Vaccibody AS Prostate Cancer Vaccines Product Portfolio
  18. 7.3.5 Vaccibody AS Recent Developments
  19. 7.4 Ultimovacs
  20. 7.4.1 Ultimovacs Company Information
  21. 7.4.2 Ultimovacs Business Overview
  22. 7.4.3 Ultimovacs Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Ultimovacs Prostate Cancer Vaccines Product Portfolio
  24. 7.4.5 Ultimovacs Recent Developments
  25. 7.5 UbiVac
  26. 7.5.1 UbiVac Company Information
  27. 7.5.2 UbiVac Business Overview
  28. 7.5.3 UbiVac Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 UbiVac Prostate Cancer Vaccines Product Portfolio
  30. 7.5.5 UbiVac Recent Developments
  31. 7.6 SOTIO
  32. 7.6.1 SOTIO Company Information
  33. 7.6.2 SOTIO Business Overview
  34. 7.6.3 SOTIO Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 SOTIO Prostate Cancer Vaccines Product Portfolio
  36. 7.6.5 SOTIO Recent Developments
  37. 7.7 Sensei Biotherapeutics
  38. 7.7.1 Sensei Biotherapeutics Company Information
  39. 7.7.2 Sensei Biotherapeutics Business Overview
  40. 7.7.3 Sensei Biotherapeutics Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Sensei Biotherapeutics Prostate Cancer Vaccines Product Portfolio
  42. 7.7.5 Sensei Biotherapeutics Recent Developments
  43. 7.8 Oncovir Inc.
  44. 7.8.1 Oncovir Inc. Company Information
  45. 7.8.2 Oncovir Inc. Business Overview
  46. 7.8.3 Oncovir Inc. Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Oncovir Inc. Prostate Cancer Vaccines Product Portfolio
  48. 7.8.5 Oncovir Inc. Recent Developments
  49. 7.9 OncBioMune Pharmaceuticals
  50. 7.9.1 OncBioMune Pharmaceuticals Company Information
  51. 7.9.2 OncBioMune Pharmaceuticals Business Overview
  52. 7.9.3 OncBioMune Pharmaceuticals Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 OncBioMune Pharmaceuticals Prostate Cancer Vaccines Product Portfolio
  54. 7.9.5 OncBioMune Pharmaceuticals Recent Developments
  55. 7.10 Momotaro-Gene Inc.
  56. 7.10.1 Momotaro-Gene Inc. Company Information
  57. 7.10.2 Momotaro-Gene Inc. Business Overview
  58. 7.10.3 Momotaro-Gene Inc. Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Momotaro-Gene Inc. Prostate Cancer Vaccines Product Portfolio
  60. 7.10.5 Momotaro-Gene Inc. Recent Developments
  61. 7.11 Mediolanum Farmaceutici
  62. 7.11.1 Mediolanum Farmaceutici Company Information
  63. 7.11.2 Mediolanum Farmaceutici Business Overview
  64. 7.11.3 Mediolanum Farmaceutici Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Mediolanum Farmaceutici Prostate Cancer Vaccines Product Portfolio
  66. 7.11.5 Mediolanum Farmaceutici Recent Developments
  67. 7.12 Medigene AG
  68. 7.12.1 Medigene AG Company Information
  69. 7.12.2 Medigene AG Business Overview
  70. 7.12.3 Medigene AG Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Medigene AG Prostate Cancer Vaccines Product Portfolio
  72. 7.12.5 Medigene AG Recent Developments
  73. 7.13 Dendreon Corporation
  74. 7.13.1 Dendreon Corporation Company Information
  75. 7.13.2 Dendreon Corporation Business Overview
  76. 7.13.3 Dendreon Corporation Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Dendreon Corporation Prostate Cancer Vaccines Product Portfolio
  78. 7.13.5 Dendreon Corporation Recent Developments
  79. 7.14 Curevac AG
  80. 7.14.1 Curevac AG Company Information
  81. 7.14.2 Curevac AG Business Overview
  82. 7.14.3 Curevac AG Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Curevac AG Prostate Cancer Vaccines Product Portfolio
  84. 7.14.5 Curevac AG Recent Developments
  85. 7.15 Cleveland BioLabs Inc.
  86. 7.15.1 Cleveland BioLabs Inc. Company Information
  87. 7.15.2 Cleveland BioLabs Inc. Business Overview
  88. 7.15.3 Cleveland BioLabs Inc. Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Cleveland BioLabs Inc. Prostate Cancer Vaccines Product Portfolio
  90. 7.15.5 Cleveland BioLabs Inc. Recent Developments
  91. 7.16 Bavarian Nordic
  92. 7.16.1 Bavarian Nordic Company Information
  93. 7.16.2 Bavarian Nordic Business Overview
  94. 7.16.3 Bavarian Nordic Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Bavarian Nordic Prostate Cancer Vaccines Product Portfolio
  96. 7.16.5 Bavarian Nordic Recent Developments
  97. 7.17 AlphaVax Inc.
  98. 7.17.1 AlphaVax Inc. Company Information
  99. 7.17.2 AlphaVax Inc. Business Overview
  100. 7.17.3 AlphaVax Inc. Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 AlphaVax Inc. Prostate Cancer Vaccines Product Portfolio
  102. 7.17.5 AlphaVax Inc. Recent Developments
  103. 7.18 Advaxis immunotherapies
  104. 7.18.1 Advaxis immunotherapies Company Information
  105. 7.18.2 Advaxis immunotherapies Business Overview
  106. 7.18.3 Advaxis immunotherapies Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Advaxis immunotherapies Prostate Cancer Vaccines Product Portfolio
  108. 7.18.5 Advaxis immunotherapies Recent Developments
  109. 7.19 Advantagene
  110. 7.19.1 Advantagene Company Information
  111. 7.19.2 Advantagene Business Overview
  112. 7.19.3 Advantagene Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Advantagene Prostate Cancer Vaccines Product Portfolio
  114. 7.19.5 Advantagene Recent Developments
8 North America
  1. 8.1 North America Prostate Cancer Vaccines Market Size by Type
  2. 8.1.1 North America Prostate Cancer Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Prostate Cancer Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Prostate Cancer Vaccines Price by Type (2021-2032)
  5. 8.2 North America Prostate Cancer Vaccines Market Size by Application
  6. 8.2.1 North America Prostate Cancer Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Prostate Cancer Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Prostate Cancer Vaccines Price by Application (2021-2032)
  9. 8.3 North America Prostate Cancer Vaccines Market Size by Country
  10. 8.3.1 North America Prostate Cancer Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Prostate Cancer Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Prostate Cancer Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Prostate Cancer Vaccines Market Size by Type
  2. 9.1.1 Europe Prostate Cancer Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Prostate Cancer Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Prostate Cancer Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Prostate Cancer Vaccines Market Size by Application
  6. 9.2.1 Europe Prostate Cancer Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Prostate Cancer Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Prostate Cancer Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Prostate Cancer Vaccines Market Size by Country
  10. 9.3.1 Europe Prostate Cancer Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Prostate Cancer Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Prostate Cancer Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Prostate Cancer Vaccines Market Size by Type
  2. 10.1.1 China Prostate Cancer Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Prostate Cancer Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Prostate Cancer Vaccines Price by Type (2021-2032)
  5. 10.2 China Prostate Cancer Vaccines Market Size by Application
  6. 10.2.1 China Prostate Cancer Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Prostate Cancer Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Prostate Cancer Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Prostate Cancer Vaccines Market Size by Type
  2. 11.1.1 Asia Prostate Cancer Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Prostate Cancer Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Prostate Cancer Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Prostate Cancer Vaccines Market Size by Application
  6. 11.2.1 Asia Prostate Cancer Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Prostate Cancer Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Prostate Cancer Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Prostate Cancer Vaccines Market Size by Country
  10. 11.3.1 Asia Prostate Cancer Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Prostate Cancer Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Prostate Cancer Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Prostate Cancer Vaccines Market Size by Type
  2. 12.1.1 SAMEA Prostate Cancer Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Prostate Cancer Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Prostate Cancer Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Prostate Cancer Vaccines Market Size by Application
  6. 12.2.1 SAMEA Prostate Cancer Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Prostate Cancer Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Prostate Cancer Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Prostate Cancer Vaccines Market Size by Country
  10. 12.3.1 SAMEA Prostate Cancer Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Prostate Cancer Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Prostate Cancer Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Prostate Cancer Vaccines Value Chain Analysis
  2. 13.1.1 Prostate Cancer Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Prostate Cancer Vaccines Production Mode & Process
  6. 13.2 Prostate Cancer Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Prostate Cancer Vaccines Distributors
  9. 13.2.3 Prostate Cancer Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst